• About Us
    • Our Team
    • Board of Directors
    • Scientific Advisory Board
  • Our Approach
    • Focus Areas
    • Collaborations
  • Our Science
    • Our Pipeline
    • QLS-111
    • Publications & Posters
  • News and Events
  • Careers
  • Contact Us
  • Skip to main content
Qlaris Bio

Qlaris Bio

Careers Contact Us
Archives for Publications and Posters

Publications & Posters

VIEW:

  • All
  • Publications
  • Posters

The below publications outline research from Qlaris Bio's initial formulation, QLS-101. Based on this research, we have now developed a new formulation of our program, called QLS-111.

Journal of Ocular Pharmacology and Therapeutics

Preclinical Pharmacokinetic Profile of Topical Ophthalmic and Intravenous Delivery of QLS-101, a Novel ATP-Sensitive Potassium Channel Opening Ocular Hypotensive Agent

June 12, 2023

Read Publication

Investigative Ophthalmology & Visual Science

Ocular Hypotensive Properties and Biochemical Profile of QLS-101, a Novel ATP-Sensitive Potassium (KATP) Channel Opening Prodrug

May 5, 2022

Read Publication

Association for Research in Vision and Ophthalmology

QLS-101 In Vivo Systemic and Ocular Toxicology and Pharmacokinetic Profiles

April 28, 2021

View Poster

Association for Research in Vision and Ophthalmology

QLS-101 In Vitro Ocular Tissue Conversion and Activity Profile

April 28, 2021

View Poster

American Glaucoma Society

CKLP1 Preclinical Efficacy and Safety Profile

February 28, 2021

View Poster

Effect of Cromakalim Prodrug 1 (CKLP1) on Aqueous Humor Dynamics and Feasibility of Combination Therapy With Existing Ocular Hypotensive Agents

October 10, 2017

Read Publication

Qlaris Bio, Inc. © 2023 All Rights Reserved Privacy Policy | Terms of Use | Accessibility Statement

This website uses cookies.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.

Accept